Guerbet

This study looked at the safety of using a contrast agent called Lipiodol Ultra Fluid together with surgical glues to block blood vessels in people with certain vascular lesions or tumors. A total of 132 adults took part. The goal was to see if this combination caused any side ef…

This study tested a new contrast agent called gadopiclenol to see if it makes brain and spine MRI scans clearer. 260 adults with known or suspected brain lesions received an MRI with and without the agent. The goal was to see if the enhanced images helped doctors better see lesio…

This study tested a new contrast agent called gadopiclenol to see if it makes body MRI scans clearer. 324 adults with known or suspected lesions in their body took part. The goal was to see if the enhanced scans helped doctors see lesion borders, internal details, and contrast be…

This study tested a new contrast agent called Elucirem (gadopiclenol) for MRI scans of brain gliomas. It involved 138 adults with new or returning brain tumors. The goal was to see if Elucirem produced better quality images than the standard agent Dotarem. Results showed Elucirem…

This study looked at how the contrast agent gadopiclenol is processed in the bodies of 36 infants up to 23 months old who needed an MRI. The goal was to measure drug levels and safety, not to treat any disease. Results help doctors use the right dose for young children.